Results 241 to 248 of about 315,907 (248)

Reprogramming Tumor‐Associated Macrophages via Targeted NAT10 Inhibition to Enhance Colorectal Cancer Immunotherapy

Advanced Science, EarlyView.
This study presents the sono‐sensitive nanorobot Sono@NAT10, which targets NAT10 condensates to reprogram tumor‐associated macrophages in colorectal cancer. By reducing the acetylation level of SRSF2 protein and activating HDAC10, Sono@NAT10 promotes M1 polarization, suppresses tumor progression, and strengthens immunotherapy. The approach demonstrates
Jiahao Zhu, Benjie Xu, Rui Hu, Bo Yang, Peipei Shen, Yu Xu, Xiaojun Zhang, Danqi Qian, Gang Wu, Shengjun Ji, Yutian Zhao, Ke Gu   +11 more
wiley   +1 more source

Outcomes of Tricuspid Transcatheter Edge-to-Edge Valve Repair in End-Stage Renal Disease. [PDF]

J Soc Cardiovasc Angiogr Interv
Rodriguez L, Pierre K, Lindenfeld J, Hung R, Absi T, Lowenstern A, Lindman B, Barker C, Goel K.   +8 more
europepmc   +1 more source

Exercise intensity and the risk of end-stage renal disease in diabetes: A nationwide population-based study. [PDF]

World J Diabetes
Bae EH, Lim SY, Kim BS, Han KD, Suh SH, Choi HS, Kim CS, Ma SK, Kim SW.   +8 more
europepmc   +1 more source

An Unexpected Culprit: Fatal Gastrointestinal Hemorrhage due to Duodenal Histoplasmosis in a Patient With End-Stage Renal Disease. [PDF]

ACG Case Rep J
Rai V, Goyal R, Vyas A, Sachdeva K, Arora K, Zia H.   +5 more
europepmc   +1 more source

Neuromuscular Electrical Stimulation During Hemodialysis Enhances Exercise Capacity in Patients with End-Stage Renal Disease: A Pilot Randomized Controlled Trial. [PDF]

J Clin Med
Machfer A, Ammar A, Ceylan Hİ, Zghal F, Daab W, Amor HH, Chtourou H, Muntean RI, Bouzid MA.   +8 more
europepmc   +1 more source

Revascularization of coronary chronic total occlusion in patients with end stage renal disease. [PDF]

Sci Rep
Tsai CT, Lu YW, Huang WC, Huang SS, Teng HI, Tsai YL, Lee WL, Lu TM.   +7 more
europepmc   +1 more source